Reproductive Factors and Incidence of Heart Failure Hospitalization in the Women's Health Initiative

Journal of the American College of Cardiology

Volumn 69, Issue 20, 2017, Pages 2517-2526

  Hall, Philip S ^a   Nah, Gregory ^a   Howard, Barbara V ^b   Lewis, Cora E ^c   Allison, Matthew A ^d   Sarto, Gloria E ^e   Waring, Molly E ^f   Jacobson, Lisette T ^g   Manson, JoAnn E ^h   Klein, Liviu ^a   Parikh, Nisha I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Delaware   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

cardiovascular disease; menarche; menopause; pregnancy; women

Indexed keywords

ADULT; AGE; ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HOSPITALIZATION; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MORBIDITY; NULLIPARA; POSTMENOPAUSE; PREGNANCY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SELF REPORT; AGED; HEART FAILURE; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; INCIDENCE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; REPRODUCTIVE HISTORY; RISK FACTOR; STATISTICS; STATISTICS AND NUMERICAL DATA; UNITED STATES; WOMEN'S HEALTH;

SEX HORMONE;

AGED; COHORT STUDIES; FEMALE; GONADAL STEROID HORMONES; HEART FAILURE; HOSPITALIZATION; HUMANS; INCIDENCE; MENARCHE; MIDDLE AGED; POSTMENOPAUSE; REPRODUCTIVE HISTORY; RISK FACTORS; STATISTICS AS TOPIC; STROKE VOLUME; UNITED STATES; VENTRICULAR REMODELING; WOMEN'S HEALTH;

EID: 85019202718     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.03.557     Document Type: Article

References (41)

1. Harvey, R.E., Coffman, K.E., Miller, V.M., Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease. Womens Health (Lond) 11 (2015), 239–257.
2. Murphy, E., Estrogen signaling and cardiovascular disease. Circ Res 109 (2011), 687–696.
3. Tunstall-Pedoe, H., Myth and paradox of coronary risk and the menopause. Lancet 351 (1998), 1425–1427.
4. Appiah, D., Schreiner, P.J., Demerath, E.W., Loehr, L.R., Chang, P.P., Folsom, A.R., Association of age at menopause with incident heart failure: a prospective cohort study and meta-analysis. J Am Heart Assoc, 5, 2016, e003769.
5. Ebong, I.A., Watson, K.E., Goff, D.C. Jr., et al. Age at menopause and incident heart failure: the Multi-Ethnic Study of Atherosclerosis. Menopause 21 (2014), 585–591.
6. Rahman, I., Akesson, A., Wolk, A., Relationship between age at natural menopause and risk of heart failure. Menopause 22 (2015), 12–16.
7. Wellons, M., Ouyang, P., Schreiner, P.J., Herrington, D.M., Vaidya, D., Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis. Menopause 19 (2012), 1081–1087.
8. Adams, J.Q., Alexander, A.M. Jr., Alterations in cardiovascular physiology during labor. Obstet Gynecol 12 (1958), 542–549.
9. Bernstein, I.M., Ziegler, W., Badger, G.J., Plasma volume expansion in early pregnancy. Obstet Gynecol 97 (2001), 669–672.
10. Carbillon, L., Uzan, M., Uzan, S., Pregnancy, vascular tone, and maternal hemodynamics: a crucial adaptation. Obstet Gynecol Surv 55 (2000), 574–581.
11. Chung, E., Leinwand, L.A., Pregnancy as a cardiac stress model. Cardiovasc Res 101 (2014), 561–570.
12. Cain, M.A., Salemi, J.L., Tanner, J.P., Kirby, R.S., Salihu, H.M., Louis, J.M., Pregnancy as a window to future health: maternal placental syndromes and short-term cardiovascular outcomes. Am J Obstet Gynecol 215 (2016), 484.e1–484.e14.
13. Fraser, A., Nelson, S.M., Macdonald-Wallis, C., et al. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation 125 (2012), 1367–1380.
14. Ness, R.B., Harris, T., Cobb, J., et al. Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med 328 (1993), 1528–1533.
15. Ngo, A.D., Roberts, C.L., Figtree, G., Association between interpregnancy interval and future risk of maternal cardiovascular disease-a population-based record linkage study. BJOG 123 (2016), 1311–1318.
16. Parikh, N.I., Cnattingius, S., Dickman, P.W., Mittleman, M.A., Ludvigsson, J.F., Ingelsson, E., Parity and risk of later-life maternal cardiovascular disease. Am Heart J 159 (2010), 215–221.e6.
17. Parikh, N.I., Cnattingius, S., Mittleman, M.A., Ludvigsson, J.F., Ingelsson, E., Subfertility and risk of later life maternal cardiovascular disease. Hum Reprod 27 (2012), 568–575.
18. Parikh, N.I., Lloyd-Jones, D.M., Ning, H., et al. Association of number of live births with left ventricular structure and function. The Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 163 (2012), 470–476.
19. Parker, D.R., Lu, B., Sands-Lincoln, M., et al. Risk of cardiovascular disease among postmenopausal women with prior pregnancy loss: the Women's Health Initiative. Ann Fam Med 12 (2014), 302–309.
20. Steenland, K., Lally, C., Thun, M., Parity and coronary heart disease among women in the American Cancer Society CPS II population. Epidemiology 7 (1996), 641–643.
21. Weinberg, E.O., Thienelt, C.D., Katz, S.E., et al. Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol 34 (1999), 264–273.
22. Parikh, N.I., Jeppson, R.P., Berger, J.S., et al. Reproductive risk factors and coronary heart disease in the Women's Health Initiative Observational Study. Circulation 133 (2016), 2149–2158.
23. Park, J.S., Jung, I., Youn, J.C., Cho, H.Y., Impact of adolescent pregnancy on hypertension in postmenopausal women. J Hypertens 34 (2016), 47–53.
24. Curb, J.D., McTiernan, A., Heckbert, S.R., et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 13 (2003), S122–S128.
25. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 19 (1998), 61–109.
26. Rosamond, W.D., Chang, P.P., Baggett, C., et al. Classification of heart failure in the Atherosclerosis Risk in Communities (ARIC) study: a comparison of diagnostic criteria. Circ Heart Fail 5 (2012), 152–159.
27. Kannel, W.B., Levy, D., Menopause, hormones, and cardiovascular vulnerability in women. Arch Intern Med 164 (2004), 479–481.
28. Petre, R.E., Quaile, M.P., Rossman, E.I., et al. Sex-based differences in myocardial contractile reserve. Am J Physiol Regul Integr Comp Physiol 292 (2007), R810–R818.
29. Seed, M., Knopp, R.H., Estrogens, lipoproteins, and cardiovascular risk factors: an update following the randomized placebo-controlled trials of hormone-replacement therapy. Curr Opin Lipidol 15 (2004), 459–467.
30. Shlipak, M.G., Chaput, L.A., Vittinghoff, E., et al. Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS). Am Heart J 146 (2003), 870–875.
31. Christian, R.C., Liu, P.Y., Harrington, S., Ruan, M., Miller, V.M., Fitzpatrick, L.A., Intimal estrogen receptor (ER)beta, but not ERalpha expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women. J Clin Endocrinol Metab 91 (2006), 2713–2720.
32. Kanaya, A.M., Herrington, D., Vittinghoff, E., et al. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/Progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 138 (2003), 1–9.
33. Thomas, P., Pang, Y., Protective actions of progesterone in the cardiovascular system: potential role of membrane progesterone receptors (mPRs) in mediating rapid effects. Steroids 78 (2013), 583–588.
34. Anderson, G.L., Limacher, M., Assaf, A.R., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291 (2004), 1701–1712.
35. Maric-Bilkan, C., Arnold, A.P., Taylor, D.A., et al. Report of the National Heart, Lung, and Blood Institute Working Group on Sex Differences Research in Cardiovascular Disease: scientific questions and challenges. Hypertension 67 (2016), 802–807.
36. Rossouw, J.E., Anderson, G.L., Prentice, R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002), 321–333.
37. Kok, H.S., van Asselt, K.M., van der Schouw, Y.T., et al. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol 47 (2006), 1976–1983.
38. Britt, K., Short, R., The plight of nuns: hazards of nulliparity. Lancet 379 (2012), 2322–2323.
39. Zhao, Z., Wang, H., Jessup, J.A., Lindsey, S.H., Chappell, M.C., Groban, L., Role of estrogen in diastolic dysfunction. Am J Physiol Heart Circ Physiol 306 (2014), H628–H640.
40. Chandra, A., Copen, C.E., Stephen, E.H., Infertility and impaired fecundity in the United States, 1982-2010: data from the National Survey of Family Growth. Natl Health Stat Report, 2013, 1–18.
41. Udell, J.A., Lu, H., Redelmeier, D.A., Long-term cardiovascular risk in women prescribed fertility therapy. J Am Coll Cardiol 62 (2013), 1704–1712.